Blood Stem Cells - immune-mediated keratitis
At present many eye pathologies have the alteration of the eye #39;s privileged immune system in common. The eye #39;s privileged immune system has the objective of protecting the eye from infections, minimizing inflammation and activating a process of complex interrelations, making it complicated ,if not impossible, to fully understand . The more we investigate micro-organisms, innate immunity, adaptive immunity, receptors,substances produced by involved cells, etc..., the more this process #39;s evolution appears to be so structured and interconnected that we have to continually revaluate it. Today #39;s treatment for immunomediate illnesses of the eye is the immunosuppression through drugs such as glucocorticoids, cyclosporine A, tacrolimus, doxycycline , etc.... As an alternative we propose immunoregulation using blood stem cells that know the organism and are able to make decisions, acting by orchestrating the healing of the eye behaving like a small pharmaceutical company that produces the right drug at the right time in these complex interrelations. IMMUNE-MEDIATED KERATITIS Immune-mediated keratitis is a non ulcerative corneal disease characterized by some of the following clinical symptoms: vascularization, edema and inflammatory cell response within the cornea and absence of uveal pathology. In the pathological process there may be temporary painful erosions, but normally the pain is minimal with respect to the dramatic symptoms. This is a pathology with unknown causes but ...
By:
Marco PolettiniHere is the original post:
Blood Stem Cells - immune-mediated keratitis - Video